Skip to content
Search

Latest Stories

RCGP calls for £2 billion investment to revamp ‘outdated’ infrastructure

RCGP calls for £2 billion investment to revamp ‘outdated’ infrastructure

RCGP chair Professor Kamila Hawthorne has underscored the urgent need to address these GP infrastructure issues to rescue primary care

The Royal College of GPs (RCGP) has urged the government to allocate at least £2 billion in funding to enhance the 'outdated' GP infrastructure, including IT systems and practice buildings.

The College, representing over 54,000 family doctors in the UK – has warned that GP practice buildings are “falling apart” and this can have a serious impact on patients’ experience and access to care and services.


In a recent poll of RCGP members, a third of the GPs (30 per cent) reported that their work PC or laptop software is “not fit for purpose”, while 33 per cent indicated that their practice building is inadequate for providing care for patients.

Additionally, 56 per cent of GPs reported that they could not effectively exchange information with NHS trusts due to fundamental inadequacies in their digital infrastructure.

RCGP stated: “If GPs are unable to easily share information with hospitals and other secondary care hubs this can lead to disjointed care and a poorer patient experience.

“Similarly, if practice buildings aren’t fit for purpose, it can have a negative impact on the care patients receive. If consultation rooms are too small and cramped, or there aren’t enough of them, this not only provides a poor experience, but also limits the number of team members a practice can employ and the appointments a practice can deliver in a day.”

The College raised concerns that these issues in physical and digital infrastructure are contributing to the unrelenting pressures facing general practice.

Highlighting the escalating challenges for doctors, the College reported that GPs and their teams delivered over 27.6 million appointments last month – over 4 million more than in August 2019 - despite having fewer fully qualified full-time GPs than five years ago.

The number of patients per fully qualified GP has now reached a staggering 2,280.

Professor Kamila Hawthorne, chair of the RCGP, emphasised: “General practice is already struggling to keep up with increasing patient need for our care, and inadequate infrastructure, whether that be out-of-date IT or practice buildings that are falling apart, only compounds these pressures.

"Our polling shows the true extent of the crisis: GPs are being held back by old IT that is unfit for purpose and working in inadequate buildings. This is a far cry from what our patients expect and deserve, and it needs to be addressed.”

She cautioned that these issues pose a major hindrance for GP teams and could have serious consequences for patients.

“Those with lung conditions such as bronchitis or chronic asthma, for example, may well be hesitant to seek treatment if their local practice is riddled with damp and mould. Likewise, if ineffective IT hampers communication between primary and secondary care then patients may not receive the treatment they need as quickly as they need it.”

Professor Hawthorne underscored the urgent need to address these infrastructure challenges if “we are going to rescue primary care.”

Therefore, the College is calling on the government to “dedicate at least £2 billion worth of funding to improve GP infrastructure - including IT systems – so that GPs and their teams can do their jobs properly and our patients’ experience and access to care is no longer compromised.”

More For You

13 pharmacists achieve RPS core advanced credential with record pass rate

The latest successful cohort includes pharmacists from both England and Scotland.

Pic credit: Getty Images

13 more pharmacists achieve RPS core advanced credential - Highest pass rate yet

The Royal Pharmaceutical Society (RPS) has announced that 13 more pharmacists have successfully completed Core Advanced Credentialling as part of the latest assessment cohort —achieving a remarkable 93% pass rate, the highest to date.

This brings the total number of pharmacists awarded the RPS core advanced credential to 113 since the launch of the Core Advanced Curriculum in 2023, with successful candidates from GP, secondary care and community settings.

Keep ReadingShow less
 Government launches call for evidence on England’s first ever men’s health strategy

Wes Streeting

Pic credit: Getty images

Call for Evidence: Streeting urges public to help shape men’s health strategy

The government is urging men of all ages to come forward and contribute to the development of England’s first-ever men’s health strategy, a key initiative under its Plan for Change.

On Thursday (24), the Department of Health and Social Care (DHSC) launched a 12-week call for evidence, seeking insights from the public, health and social care professionals, academics and employers on ways to prevent and tackle the biggest issues facing men.

Keep ReadingShow less
Slamannan Village Pharmacy sold after 31 years

Slamannan Village Pharmacy

Slamannan Village Pharmacy sold after 31 years

A pharmacy in a small village in Scotland that has served its community for 31 years, has been bought by a group that operates 43 pharmacies across Scotland.

Slamannan Village Pharmacy is heavily relied on by locals sourcing their prescriptions from the village’s sole GP surgery.

Keep ReadingShow less
Kinnock highlights employers’ role in making community pharmacy jobs attractive

The new funding uplift our commitment to rebuilding the sector: Kinnock

Kinnock: ‘Employers have a key role in making community pharmacy jobs attractive’

Health minister Stephen Kinnock has emphasised that employers have a crucial role to play in retaining staff and making careers in community pharmacy more attractive.

His comments came in response to a written question from Victoria Collins MP, the Liberal Democrat spokesperson for science and technology, who asked what steps the Department of Health and Social Care is taking to address staff shortages and prevent the closure of local pharmacies.

Keep ReadingShow less
MHRA approves Pfizer Hympavzi (marstacimab) for haemophilia treatment

Marstacimab is currently being assessed by NICE and the Scottish Medicines Consortium for use on the NHS

gettyimages

Marstacimab approved for haemophilia treatment, Pfizer aims for NHS availability

The Medicines and Healthcare products Regulatory Agency (MHRA) has approved Hympavzi(marstacimab) to prevent or reduce bleeding in patients aged 12 years and older, weighing at least 35kg, who have severe haemophilia A or B.

Developed by Pfizer scientists, this groundbreaking treatment is the first of its kind to target a protein involved in the blood clotting process.

Keep ReadingShow less